Thomas Flaten
Stock Analyst at Lake Street
(0.97)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DERM Journey Medical | Maintains: Strong Buy | 9 13 | 7.87 | 65.18% | 2 | Aug 13, 2025 | |
RPID Rapid Micro Biosyste... | Initiates Coverage On: Buy | 8 | 3.26 | 145.4% | 1 | Jul 28, 2025 | |
DMAC DiaMedica Therapeuti... | Maintains: Strong Buy | 11 14 | 4.6 | 204.35% | 2 | Jul 18, 2025 | |
AYTU Aytu BioPharma | Initiates Coverage On: Buy | 8 | 2.24 | 257.14% | 1 | Jul 1, 2025 | |
OCX OncoCyte | Maintains: Strong Buy | 5 8 | 3.2 | 150% | 6 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 3 2 | n/a | n/a | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 35 | 19.13 | 82.96% | 6 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 17 9 | 9.6 | -6.25% | 5 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 5 | 4.26 | -3.76% | 5 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 8 | 3.87 | 106.72% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 6 | 2.79 | 115.05% | 2 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 9 | 4.5 | 100% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 1 | n/a | n/a | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | 0.72 | 316.67% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 11 | 2.46 | 347.15% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 25 | 22.43 | 11.46% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14400 1440 | 2.08 | 69130.77% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | May 13, 2022 |